Activating Compound | Comment | Organism | Structure |
---|---|---|---|
atenolol | 2 mM, 32% activation | Rattus norvegicus | |
corticosterone | 0.5 mM, 18% activation | Rattus norvegicus | |
propranolol | 2 mM, 18% activation | Rattus norvegicus | |
simvastatin | 0.5 mM, 32% activation | Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
aspirin | 2 mM, 84% inhibition | Rattus norvegicus | |
corticosterone | 2 mM, 13% inhibition | Rattus norvegicus | |
L-phenylalanine | 2 mM, 24% inhibition | Rattus norvegicus | |
levamisole | 0.5 mM, 91% inhibition | Rattus norvegicus | |
polyphenol-rich beverages | 21% inhibition | Rattus norvegicus | |
progesterone | 0.5 mM, 29% inhibition | Rattus norvegicus | |
theophylline | 2 mM, 77% inhibition | Rattus norvegicus |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Rattus norvegicus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
heart | - |
Rattus norvegicus | - |
heart | expressed in heart, demonstrated by RT-PCR | Rattus norvegicus | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.031 | - |
specific activity in heart | Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
4-nitrophenyl phosphate + H2O | - |
Rattus norvegicus | 4-nitrophenol + phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
alkaline phosphatase | - |
Rattus norvegicus |
ALP | - |
Rattus norvegicus |
tissue-nonspecific ALP | - |
Rattus norvegicus |
tissue-specific intestinal ALP type II | - |
Rattus norvegicus |
Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|
37 | - |
assay at | Rattus norvegicus |
pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|
10.4 | - |
assay at | Rattus norvegicus |